DDrare: Database of Drug Development for Rare Diseases

Teicoplanin (DrugBank: Teicoplanin)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	1
299	嚢胞性線維症	1

70. 広範脊柱管狭窄症　［臨床試験数：91，薬物数：195（DrugBank：54），標的遺伝子数：60，標的パスウェイ数：85］

Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 91 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04341831 (ClinicalTrials.gov)	April 15, 2020	8/4/2020	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Lumbar Spinal Stenosis;Lumbar Disc Herniation;Scoliosis Lumbar Region;Lumbar Spondylolisthesis;Lumbar Disc Lesion	Drug: Teicoplanin	Bezmialem Vakif University	NULL	Not yet recruiting	18 Years	N/A	All	120	Phase 3	NULL

299. 嚢胞性線維症　［臨床試験数：1,592，薬物数：1,539（DrugBank：255），標的遺伝子数：81，標的パスウェイ数：162］

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1,592 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04176328 (ClinicalTrials.gov)	October 25, 2019	8/11/2019	Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	An Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	Cystic Fibrosis	Drug: Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.	Neupharma Srl	Sintesi Research Srl;Aptuit Srl;Pari Pharma GmbH	Completed	18 Years	N/A	All	12	Phase 1	Italy